Mary Elmer leads a team for the global patient engagement program at the office for the Chief Patient Officer at Merck & Co., Inc. This group is actively involved in bringing the voice of the patient into the drug development process at Merck through strong collaborative partnerships with patients and organizations serving patients. Mary is a board-certified nurse practitioner with over 18 years of experience at Merck, working in all phases of drug development and implementing global strategic initiatives. Mary is a member of the Global Diversity and Inclusion council at Merck and co-leads the diversity in US clinical trials initiative, which seeks to ensure our clinical trials are representative of diverse patient groups. Mary is a member of TransCelerate Biopharma, and leads a work stream on patient engagement.
Mary obtained her Master of Science in Nursing degree from the University of Pennsylvania She is a Six Sigma green belt who has experience in executing organizational change and cross-company initiatives, such as implementing clinical trial data sharing at Merck, in alignment with trade organizations (EFPIA/PHRMA) and regulatory bodies.
We are committed to improving health and well-being around the world.From developing new therapies that treat and prevent disease to helping people in need, we are guided by a rich legacy and inspired by a shared vision.